Home/Filings/4/0001214659-21-007596
4//SEC Filing

Oram Jeffrey 4

Accession 0001214659-21-007596

CIK 0001677077other

Filed

Jul 15, 8:00 PM ET

Accepted

Jul 16, 5:00 PM ET

Size

7.7 KB

Accession

0001214659-21-007596

Insider Transaction Report

Form 4
Period: 2021-07-14
Oram Jeffrey
Director
Transactions
  • Award

    Stock Options (Right to Buy)

    2021-06-15+300,000300,000 total
    Exercise: $2.50Exp: 2026-09-12Common Stock (300,000 underlying)
  • Award

    Restricted Stock Grant

    2021-06-15+100,000100,000 total
    Exp: 2024-09-13Common Stock (100,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.
  • [F2]The restricted stock grant vest contemporaneously with the Options (as defined below).
  • [F3]The stock options (the "Options") vest in 36 equal monthly installments commencing on September 13, 2021 and are exercisable upon vesting.

Issuer

Alzamend Neuro, Inc.

CIK 0001677077

Entity typeother

Related Parties

1
  • filerCIK 0001864444

Filing Metadata

Form type
4
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 5:00 PM ET
Size
7.7 KB